Assessment of hospice nurses' technique in the use of inhalers and nebulizers

Journal of Palliative Medicine

Volumn 10, Issue 3, 2007, Pages 665-676

  Scarpaci, Laura T ^a   Tsoukleris, Mona G ^b   McPherson, Mary Lynn ^b  

^a excelleRx Inc   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; LEVALBUTEROL; MORPHINE; OPIATE DERIVATIVE; SALBUTAMOL; SALMETEROL; TIOTROPIUM BROMIDE;

ACCURACY; ARTICLE; CERTIFICATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEMOGRAPHY; DISTRESS SYNDROME; DRUG DELIVERY SYSTEM; DYSPNEA; HOSPICE NURSING; HUMAN; INHALER; METERED DOSE INHALER; NEBULIZER; PATIENT EDUCATION; PHARMACIST; POWDER INHALER; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SYMPTOMATOLOGY; TECHNIQUE;

DYSPNEA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOSPICE CARE; HUMANS; MARYLAND; NEBULIZERS AND VAPORIZERS; NURSES; PALLIATIVE CARE; QUESTIONNAIRES;

EID: 34347389757     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2006.0180     Document Type: Article

References (27)

1. American Thoracic Society: Dyspnea: Mechanisms, assessment, and management. Am J Respir Crit Care Med 1999;159:321-340.
2. Dudgeon DJ, Lertzman M: Dyspnea in the advanced cancer patient. J Pain Symptom Manage 1998;16:212-219.
3. Reuben DB, Mor V: Dyspnea in terminally ill cancer patients. Chest 1986;89:234-236.
4. Fainsinger R, Maceachern T, Hanson, Miller MJ, Bruera E: Symptom control during the last week of life on a palliative care unit. J Palliat Care 1991;7:5-11.
5. Edmonds, P, Karlsen S, Khan S, Addington-Hall J: A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med 2001;15:287-295.
6. McCarthy M, Lay M, Addington-Hall J: Dying from heart disease. J R Coll Physicians Lond 1996;30:325-328.
7. Elkington H, White P, Addington-Hall J, Higgs R, Pettinari C: The last year of life of COPD: A qualitative study of symptoms and services. Respir Med 2004;98: 439-445.
8. Moody LE, Fraser M, Yarandi H: Effects of guided imagery in patients with chronic bronchitis and emphysema. Clin Nurs Res 1993;2:478-486.
9. Sorenson HM: Dyspnea assessment. Respir Care 2000; 45:1331-1338.
10. Mahler DA, Weinberg DH, Wells CK, Feinstein AR: The measurement of dyspnea: Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984;85:751-758.
11. Ware JE Jr, Sherbourne CD: The MOS-36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
12. Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure for chronic airflow limitation: The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-1327.
13. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K: The Edmonton symptom assessment system (ESAS): A simple method for the assessment of palliative care patients. J. Palliat Care 1991;7:6-9.
14. Webb M, Moody LE, Mason LA: Dyspnea assessment and management in hospice patients with pulmonary disorders. Am J Hosp Palliat Care 2000;17:259-264.
15. Janssens JP, Muralt B, Titelion V: Management of dyspnea in severe chronic obstructive pulmonary disease. J Pain Symptom Manage 2000;19:378-392.
16. Brown SJ, Eichner SF, Jones JR: Nebulized morphine for relief of dyspnea due to chronic lung disease. Ann Pharmacother 2005;39:1088-1092.
17. Potter M, McPherson ML: Characterization of aerosolized respiratory medication use in a hospice population. Abstracts of the 2005 American Academy of Hospice and Palliative Medicine and Hospice and Palliative Nurses Association Annual Meeting, January 2005.
18. Lahdensuo A, Muittari A: Bronchodilator effects of a fenoterol metered dose inhaler and fenoterol powder in asthmatics with poor inhaler technique. Eur J Respir Dis 1986;68:332-335.
19. Johnson DH, Robart P: Inhaler technique of outpatients in the home. Respir Care 2000;45:1182-1187.
20. Lenney J, Innes JA, Crompton GK: Inappropriate inhaler use: Assessment of use and patient preference of seven inhalation devices. Respir Med 2000;94:496-500.
21. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH: Inhaled corticosteroids for asthma therapy: Patient compliance, devices, and inhalation technique. Chest 2000;117:542-550.
22. Interiano B, Guntupalli KK: Metered-dose inhalers: Do health care providers know what to teach? Arch Intern Med 1993;153:81-85.
23. Guidry GG, Brown WD, Stogner SW, George RB: Incorrect use of metered dose inhalers by medical personnel. Chest. 1992;101:31-33.
24. Hanania NA, Wittman R, Kesten S, Chapman KR: Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994;105:111-116.
25. Potter M, McPherson ML, Pradel F, Tsoukleris M. Assessment of technique and perceived benefit of inhaled medications at the end of life: A pilot study. Abstracts of the 2005 Hospice Network of Maryland Annual Meeting, November 2005.
26. Pradel F, Weiss SR, Magder LS, Tsoukleris M, Fahlman C, Bollinger ME: Preliminary validation of the "inhalation device skill assessment tool." J Soc Adm Pharm 2003;20:18-24
27. American Thoracic Society. Statement on home care for patients with respiratory disorders. Am J Respir Crit Care Med 2005;171:1443-1464.